Completed PHASE1 INTERVENTIONAL 2-arm NCT02004301

A Study to Investigate Delayed-release Tablets

A Pilot Pharmacoscintigraphic Clinical Study to Investigate the Behaviour of Delayed-release Tablets Consisting of a Diclofenac Potassium Core Coated With Barrier Granules, in Healthy Volunteers

Sponsor: BDD Pharma Ltd

Conditions Pain

Interventions Radiolabelled T4 Tablet Radiolabelled T6 Tablet

Updated 6 times since 2017 Last updated: Apr 9, 2014 Started: Jan 31, 2014 Primary completion: Mar 31, 2014 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Pain, this trial is completed. The trial is conducted by BDD Pharma Ltd and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2018 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2018 [monthly]

Completed PHASE1

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

BDD Pharma Ltd
Drug Delivery International Ltd

Data source: BDD Pharma Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Glasgow, United Kingdom